Cargando…

Myeloid-derived suppressor cells in ovarian cancer: friend or foe?

Although previous decades contributed to major progress in targeted therapy of many malignancies, the treatment of gynaecological cancers remains a challenging task. In the evidence of rising cancer mortality, the search for new methods of treatment is a dire need. Exploring the mechanisms of intera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walankiewicz, Monika, Grywalska, Ewelina, Polak, Grzegorz, Kotarski, Jan, Siwicka-Gieroba, Dorota J., Roliński, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2017
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820985/ https://www.ncbi.nlm.nih.gov/pubmed/29472817 http://dx.doi.org/10.5114/ceji.2017.72823

Ejemplares similares

The Increase of Circulating PD-1- and PD-L1-Expressing Lymphocytes in Endometriosis: Correlation with Clinical and Laboratory Parameters
por: Walankiewicz, Monika, et al.
Publicado: (2018)

Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients – preliminary study
por: Rudnicka, Julia, et al.
Publicado: (2015)

Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters
por: Grywalska, Ewelina, et al.
Publicado: (2018)

CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis
por: Abramiuk, Monika, et al.
Publicado: (2020)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
por: Lv, Meng, et al.
Publicado: (2019)

CLTA-4 Expression Is Associated with the Maintenance of Chronic Inflammation in Endometriosis and Infertility
por: Abramiuk, Monika, et al.
Publicado: (2021)

Subpopulations of natural killer-T-like cells before and after surgical treatment of laryngeal cancer
por: Klatka, Janusz, et al.
Publicado: (2017)

Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?
por: Wen, Liang, et al.
Publicado: (2016)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art
por: Suszczyk, Dorota, et al.
Publicado: (2021)

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
por: Andina, Nicola, et al.
Publicado: (2022)

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
por: Okła, Karolina, et al.
Publicado: (2019)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Credibility of the Neutrophil-to-Lymphocyte Count Ratio in Severe Traumatic Brain Injury
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2021)

Friend and Foe
Publicado: (1890)

Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?
por: Baranello, Cinzia, et al.
Publicado: (2012)

Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
por: Chaib, Mehdi, et al.
Publicado: (2020)

Toll-Like Receptors-2 and -4 in Graves’ Disease—Key Players or Bystanders?
por: Polak, Agnieszka, et al.
Publicado: (2019)

Lung microbiome – a modern knowledge
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2020)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Revisiting ovarian cancer microenvironment: a friend or a foe?
por: Zhang, Boyi, et al.
Publicado: (2017)

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2020)

PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection—“Rheumatic Fever” of the 21st Century?
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2021)

Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis
por: Wawrzycki, Bartłomiej, et al.
Publicado: (2018)

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
por: Grywalska, Ewelina, et al.
Publicado: (2018)

Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
por: Grywalska, Ewelina, et al.
Publicado: (2019)

Oxygen, the lung and the diver: friends and foes?
por: van Ooij, Pieter-Jan A.M., et al.
Publicado: (2016)

Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance
por: Klatka, Janusz, et al.
Publicado: (2013)

Cytotoxicity of Iron (III), Molybdenum (III), and their Mixtures in BALB/3T3 and HepG2 Cells
por: Terpiłowska, Sylwia, et al.
Publicado: (2018)

Cell Viability in Normal Fibroblasts and Liver Cancer Cells After Treatment with Iron (III), Nickel (II), and their Mixture
por: Terpiłowska, Sylwia, et al.
Publicado: (2018)

The Female Reproductive Tract Microbiota: Friends and Foe
por: Kumar, Lokesh, et al.
Publicado: (2023)

Media and breastfeeding: Friend or foe?
por: Brown, Jane D, et al.
Publicado: (2008)

Friend to the brain, foe to the spine
por: Maxmen, Amy
Publicado: (2008)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h71h39522n0jmbmfdperkfe6ih